Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-94P refers to a pseudogene derived from the U7 small nuclear RNA gene family in the human genome. U7 small nuclear RNA (snRNA) itself is a functional non-coding RNA that plays an important role in the 3′ end processing of histone pre-mRNAs in metazoans, but pseudogenes such as RNU7-94P are generally non-functional genomic relics and do not produce active RNA molecules or participate in known biological pathways. Pseudogenes, by definition, are typically not transcribed into functional products and do not act as therapeutic targets, disease markers, or direct regulators in cellular biology[1][3][4]. Key notes: - The U7 snRNA (not the pseudogene) is important for histone mRNA 3' end formation, but RNU7-94P is a pseudogene variant and is not known to encode a functional RNA or protein[1][3][4]. - Pseudogenes like RNU7-94P are sometimes annotated in genomic studies due to sequence homology, but without accompanying promoter or regulatory elements needed for function, and there is no evidence they act as biological or therapeutic targets[3][4]. - No drugs, diseases, biomarkers, or safety concerns are directly associated with RNU7-94P, as it is not functional. Summary of correctness: The target "RNA, U7 small nuclear 94 pseudogene" (RNU7-94P) is incomplete or incorrect as a therapeutic or biological target. It is a pseudogene, has no known function, and does not fit established categories such as receptor, enzyme, transporter, or transcription factor[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 94 pseudogene (RNU7-94P).